PTCT Overview
Upcoming Projects (PTCT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (PTCT)
-
A Third Look: Discussing the potential of uniQure's gene therapy AMT-130 and how it compares to PTC Therapeutics candidate, PTC518, in patients with Huntington's disease.
Tickers: QURE, PTCT
Executed On: Dec 16, 2024 at 05:30 PM EST -
A Second Look: Discussing the potential of uniQure's gene therapy AMT-130 and how it compares to PTC Therapeutics candidate, PTC518, in patients with Huntington's disease.
Tickers: QURE, PTCT
Executed On: Dec 16, 2024 at 04:45 PM EST -
Discussing the potential of uniQure's gene therapy AMT-130 and how it compares to PTC Therapeutics candidate, PTC518, in patients with Huntington's disease.
Tickers: QURE, PTCT
Executed On: Dec 16, 2024 at 09:00 AM EST -
A second look: Discussing the potential of uniQure's gene therapy AMT-130 and PTC Therapeutics candidate PTC518 in Huntington's Disease.
Tickers: QURE, PTCT
Executed On: Jun 30, 2023 at 12:30 PM EDT -
Discussing the potential of uniQure's gene therapy AMT-130 and PTC Therapeutics candidate PTC518 in Huntington's Disease.
Tickers: QURE, PTCT
Executed On: Jun 27, 2023 at 10:45 AM EDT -
Discussing the treatment landscape for Huntington's Disease with special attention to PTC 518 and AMT-130
Tickers: QURE, PTCT, IONS, RHHBY
Executed On: Jul 19, 2022 at 08:15 AM EDT -
Discussing standard of care for SMA and potential of PTC Therapeutics' Evrysdi
Tickers: PTCT, RHHBY
Executed On: May 25, 2022 at 05:30 PM EDT
Upcoming & Overdue Catalysts (PTCT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (PTCT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
